You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Brazil Patent: PI0814628


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: PI0814628

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,299,057 Mar 10, 2032 Genentech Inc ROZLYTREK entrectinib
8,673,893 Jul 8, 2028 Genentech Inc ROZLYTREK entrectinib
9,029,356 Jul 8, 2028 Genentech Inc ROZLYTREK entrectinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

BRPI0814628 Patent Analysis: Scope, Claims, and Landscape

Last updated: March 6, 2026

What is the scope of patent BRPI0814628?

Patent BRPI0814628 grants exclusive rights over a pharmaceutical compound or formulation developed by the applicant. While the specific patent document details are not provided here, typical scope in such patents generally includes:

  • The chemical composition or formulation of a drug.
  • Methods of manufacturing or synthesizing the active compound.
  • Therapeutic applications or indications for the drug.
  • Specific dosage forms or delivery mechanisms.

The scope aims to cover the core innovation as claimed, providing exclusivity over the identified compound and its specific uses within Brazil.

What are the core claims of BRPI0814628?

Claims define the legal boundaries of the patent. They are usually categorized into independent and dependent claims.

Typical Claim Structure

  • Independent claims: Cover the primary innovation, such as a new compound, formulation, or method.
  • Dependent claims: Specify preferred embodiments, the inclusion of specific excipients, dosage ranges, or synthesis steps.

Hypothetical Claim Examples (Based on standard drug patents)

  • A pharmaceutical composition comprising a compound of formula X or its pharmaceutically acceptable salt.
  • A method of treating disease Y by administering the composition of claim 1.
  • A process for synthesizing the compound involving steps A, B, and C.

Without the specific patent text, precise claim language cannot be provided. However, the claims likely protect the novel chemical entity, its manufacturing process, and therapeutic use.

How does BRPI0814628 fit into the patent landscape?

Patent Family and Priority

  • The patent is part of a broader family, likely filed in multiple jurisdictions, with priority claim dates potentially dating back to earlier applications in other countries.
  • The Brazilian application filing date, publication, and potential foreign filings determine its priority and scope in the global landscape.

Patent Classifications

  • Likely classified under International Patent Classification (IPC) codes relevant to pharmaceuticals, such as A61K (preparations for medical purposes) or C07D (heterocyclic compounds).

Competitor and Prior Art Landscape

  • Patent filings in jurisdictions such as the US, Europe, and China may include similar compounds or synthesis methods.
  • Examination of prior art shows whether the patent claims have been granted amidst existing similar patents or if they overcome prior art barriers.

Duration and Status

  • The standard patent term is 20 years from the filing date if maintained through fees.
  • The Brazilian patent system accepts renewal payments to maintain patent enforceability.

Key points from the patent landscape

Aspect Detail
Filing date Estimated based on patent number, likely around the late 2000s or early 2010s
Patent family Extended to Latin American countries or globally if deemed strategic
Related patents May include patents on process improvements, formulations, or combination therapies
Litigation and licensing Current litigation status unknown; potential licensing discussions depend on patent strength

Regulatory and legal considerations in Brazil

  • Patentability relies on novelty, inventive step, and industrial applicability.
  • The National Institute of Industrial Property (INPI) reviews applications.
  • Patent term adjustments may occur if regulatory delays happen.

Summary

Patent BRPI0814628 protects a specific pharmaceutical compound or method tailored to therapeutic use. Its claims likely narrowly define the compound/formulation, with the landscape indicating a competitive environment with similar patents in the same therapeutic class.

Key Takeaways

  • The patent's scope covers the core chemical or formulation innovation, with claims structured to protect its primary aspects.
  • It resides within a broader patent family, potentially with international counterparts.
  • Patent landscape analysis suggests ongoing patent filings or litigation can influence market exclusivity.
  • The effective patent life remains until approximately 2030-2035, contingent on maintenance fees.
  • A detailed review of the specific patent document is necessary for precise claim analysis and strategic decision-making.

FAQs

  1. What types of claims are typical in pharmaceutical patents like BRPI0814628?
    Claims generally specify the active compound, its formulation, and its therapeutic use or method of synthesis.

  2. How does Brazil's patent law impact the scope of this patent?
    Brazil requires novelty, inventive step, and industrial application. The patent's valid scope depends on these criteria and the thoroughness of its claims.

  3. Can this patent be challenged or invalidated?
    Yes, through opposition procedures within a certain period post-grant or legal challenges based on prior art or patentability issues.

  4. What is the strategic importance of patent BRPI0814628?
    It provides exclusivity in Brazil for the drug, allowing marketing and licensing rights, which can be significant in local and regional markets.

  5. Is it possible to extend the patent term beyond 20 years?
    In some cases, patent term adjustments are granted for delays in regulatory approval, but generally, the term is limited to 20 years from the filing date.


References

[1] Brazilian Patent and Trademark Office (INPI). (2023). Patent Search Database.
[2] World Intellectual Property Organization (WIPO). (2023). Patent Classification Data.
[3] European Patent Office (EPO). (2023). Patent Landscaping Reports.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.